Medicine and Dentistry
Patient
69%
Ketamine
50%
Fluorine-18
50%
Depression
50%
Spontaneous Remission
50%
Psychosis
50%
Dopamine
50%
Voxel-Based Morphometry
50%
DOPA
50%
Gray Matter
50%
Therapeutic Procedure
40%
Prefrontal Cortex
30%
Dopamine Metabolism
20%
Infusion
16%
Anticipation
16%
Symptom
16%
Feedback System
11%
Methadone
11%
Antidepressant
11%
Drug Effect
11%
Dopamine Agonist
10%
Brain
10%
Insula
5%
Male
5%
Female
5%
Placebo
5%
Anhedonia
5%
Hallucinogen
5%
Amaurosis
5%
Drug Administration
5%
Antidepressant Activity
5%
Pathophysiology
5%
Dopaminergic System
5%
Brain Cortex Lesion
5%
Effect Size
5%
Treatment Response
5%
Positron Emission Tomography
5%
Magnetic Resonance Imaging
5%
Pathology
5%
Treatment-Resistant Schizophrenia
5%
Neuroscience
Psychosis
100%
Voxel-Based Morphometry
50%
Ketamine
50%
Positron Emission Tomography
50%
Dopamine
50%
Depression
50%
Antipsychotic
50%
DOPA
50%
Ventral Tegmental Area
22%
Brain Areas
22%
Dementia Praecox
21%
Antidepressant
16%
Dopaminergic
15%
Brain
14%
Ventral Striatum
11%
Amygdala
11%
Putamen
11%
Dorsal Striatum
11%
Nucleus Accumbens
11%
Frontal Lobe
10%
Striatum
6%
Psychotomimetic
5%
Placebo
5%
Anhedonia
5%
Magnetic Resonance Imaging
5%
In Vivo
5%
Treatment-Resistant Schizophrenia
5%
